Correlation Between Marizyme and Magenta Therapeutics
Can any of the company-specific risk be diversified away by investing in both Marizyme and Magenta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Marizyme and Magenta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Marizyme and Magenta Therapeutics, you can compare the effects of market volatilities on Marizyme and Magenta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Marizyme with a short position of Magenta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Marizyme and Magenta Therapeutics.
Diversification Opportunities for Marizyme and Magenta Therapeutics
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Marizyme and Magenta is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Marizyme and Magenta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Magenta Therapeutics and Marizyme is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Marizyme are associated (or correlated) with Magenta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Magenta Therapeutics has no effect on the direction of Marizyme i.e., Marizyme and Magenta Therapeutics go up and down completely randomly.
Pair Corralation between Marizyme and Magenta Therapeutics
If you would invest 12.00 in Marizyme on September 3, 2024 and sell it today you would lose (7.00) from holding Marizyme or give up 58.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 0.4% |
| Values | Daily Returns |
Marizyme vs. Magenta Therapeutics
Performance |
| Timeline |
| Marizyme |
| Magenta Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Marizyme and Magenta Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Marizyme and Magenta Therapeutics
The main advantage of trading using opposite Marizyme and Magenta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Marizyme position performs unexpectedly, Magenta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Magenta Therapeutics will offset losses from the drop in Magenta Therapeutics' long position.| Marizyme vs. NRx Pharmaceuticals | Marizyme vs. RenovaCare | Marizyme vs. Aerovate Therapeutics | Marizyme vs. Akari Therapeutics PLC |
| Magenta Therapeutics vs. Assembly Biosciences | Magenta Therapeutics vs. Instil Bio | Magenta Therapeutics vs. Nuvation Bio | Magenta Therapeutics vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stocks Directory Find actively traded stocks across global markets |